Stimulus amplification, efficacy, and the operational model. Part I - Binary complex occupancy mechanisms

Journal of Theoretical Biology

Volumn 198, Issue 3, 1999, Pages 329-346

  Trzeciakowski, J P ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISSOCIATION CONSTANT; MATHEMATICAL MODEL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

EID: 0033532666     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.1999.0919     Document Type: Article

References (35)

1. Ariëns, E. J. (1954). Affinity and intrinsic efficacy in the theory of competitive inhibition. Part I. Problems and theory. Arch. Int. Pharmacodyn. Ther. 99, 32-49.
2. Barlow, R. B., Scott, K. A. & Stephenson, R. P. (1967). An attempt to study the effect of chemical structure on the affinity and efficacy of compounds related to acetylcholine. Br. J. Pharmacol. 21, 509-522.
3. Bennett, J. P. (1978). Methods in binding studies. In: Neurotransmitter Receptor Binding (Yamamura, H. I., Enna, S. J. & Kuhar, M. J., eds) pp. 57-90. New York: Raven Press.
4. Black, J. W. & Leff, P. (1983). Operational models of pharmacological agonism. Proc. R. Soc. B. 220, 141-162.
5. Black, J. W., Leff, P., Shankley, N. P. & Wood, J. (1985). An operational model of pharmacological agonism: The effect of E/[A] curve shape on agonist dissociation constant estimation. Br. J. Pharmacol. 84, 561-571.
6. Brown, E. M., Fedak, S. A., Woodard, C. J., Aurbach, G. D. & Rodbard, D. (1976). β-Adrenergic receptor interactions. Direct comparison of receptor interaction and biological activity. J. Biol. Chem. 251, 1239-1246.
7. Burt, D. R. (1986). Receptor binding methodologies and analysis. In: Receptor Binding in Drug Research (O'Brian, R. A., ed.) pp. 3-30. New York: Dekker.
8. Colquhoun, D. (1987). Affinity, efficacy, and receptor classification: Is the classical theory stil useful? In: Perspectives on Receptor Classification (Black, J. W., Jenkinson, D. H. & Gerskowitch, V. P., eds) pp. 103-114. New York: Alan R. Liss.
9. Costa, T., Ogino, Y., Munson, P. J., Onaran, H. O. & Rodbard, D. (1992). Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: Thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol. 41, 549-560.
10. Furchgott, R. F. (1966). The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. In: Advances in Drug Research (Harper, N. J. & Simmonds, A. B., eds) pp. 21-55. London: Academic Press.
11. Furchgott, R. F. & Bursztyn, P. (1967). Comparison of dissociation constants and of relative efficacies of selective agonists acting on parasympathetic receptors. Ann. N. Y. Acad. Sci. 144, 882-889.
12. Herepath, M. L. & Broadley, K. J. (1990). Affinities of full agonists for cardiac β-adrenoceptors calculated by use of in vitro desensitization. Naunyn-Schmiedeberg's Arch. Pharmacol. 341, 525-533.
13. Kenakin, T. P. (1985). The quantification of relative efficacy of agonists. J. Pharmacol. Meth. 13, 281-308.
14. Kenakin, T. P. (1993). Pharmacologic Analysis of Drug-Receptor Interaction 2nd Edn. New York: Raven Press.
15. Kenakin, T. P. (1996). The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol. Rev. 48, 413-463.
16. Lauffenburger, D. & Linderman, J. J. (1993). Signal transduction. In: Receptors: Models for Binding, Trafficking, and Signaling pp. 181-235. New York: Oxford University Press.
17. Leff, P. (1996). The two-state model of agonist action: Challenges to pharmacological receptor theory. Proc. West. Pharmacol. Soc. 39, 67-68.
18. Leff, P. & Harper, D. (1989). Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates? J. Theor. Biol. 140, 381-397.
19. Leff, P., Martin, G. R. & Morse, J. M. (1985). Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants. Br. J. Pharmacol. 85, 655-663.
20. Mackay, D. (1966). The mathematics of drug-receptor interactions. J. Pharm. Pharmacol. 18, 201-222.
21. Mackay, D. (1977). A critical survey of receptor theories of drug action. In: Kinetics of Drug Action (Van Rossum, J. M., ed.) pp. 169-254. New York: Springer-Verlag.
22. Mackay, D. (1988). Continuous variation of agonist affinity constants. Trends Pharmacol. Sci. 9, 156-157.
23. Mak, C. K., Avalos, M., Randall, P. K., Kwan, S. W., Abell, C. W., Neumeyer, J. L., Whisennand, R. & Wilcox, R. E. (1996). Improved models for pharmacological null experiments: Calculation of drug efficacy at recombinant D1A dopamine receptors stably expressed in clonal cell lines. Neuropharmacol. 35, 549-570.
24. Rodbard, D. (1973). Mathematics of hormone-receptor interaction. I. Basic principles. Adv. Exp. Med. Biol. 36, 289-326.
25. Ruffolo, R. R. Jr. (1982). Important concepts of receptor theory. J. Autonom. Pharmacol. 2, 277-295.
26. Ruffolo, R. R. Jr., Rosing, E. L. & Waddell, J. E. (1979). Receptor interactions of imidazolines. I. Affinity and efficacy for alpha adrenergic receptors in rat aorta. J. Pharmacol. Exp. Ther. 209, 429-436.
27. Stephenson, R. P. (1956). A modification of receptor theory. Br. J. Pharmacol. 11, 379-393.
28. Strickland, S. & Loeb, J. N. (1981). Obligatory separation of hormone binding and biological response curves in systems dependent upon secondary mediators of hormone action. Proc. Nat. Acad. Sci. 78, 1366-1370.
29. Swillens, S. (1995). Interpretation of binding curves obtained with high receptor concentrations: Practical aid for computer analysis. Mol. Pharmacol. 47, 1197-1203.
30. Trzeciakowski, J. P. (1996). Analysis of stimulus-response chains using nonlinear dynamics. J. Pharmacol. Toxicol. Meth. 36, 103-121.
31. van den Brink, F.G. (1977). General theory of drug-receptor interactions: Drug-receptor interaction models. Calculation of drug parameters. In: Kinetics of Drug Action (Van Rossum, J. M., ed.) pp. 169-254. New York: Springer-Verlag.
32. van Rossum, J. M. (1966). Limitations of molecular pharmacology. Some implications of the basic assumptions underlying calculations on drug-receptor interactions and the significance of biological drug parameters. In: Advances in Drug Research (Harper, N. J. & Simmonds, A. B., eds) pp. 189-234. London: Academic Press.
33. Waud, D. R. (1968). Pharmacological receptors. Pharmacol. Rev. 20, 49-88.
34. Waud, D. R. (1969). On the measurement of the affinity of partial agonists for receptors. J. Pharmacol. Exp. Ther. 170, 117-122.
35. Weiss, J. M., Morgan, P. H., Lutz, M. W. & Kenakin, T. P. (1996). The cubic ternary complex receptor-occupancy model III. Resurrecting efficacy. J. Theor. Biol. 181, 381-397.